Subventions financées

The common end stage pathology of neurodegenerative diseases including Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS) is neuronal death.

Spinal cord injury (SCI) is a devastating medical condition that forever changes the trajectory of life.

Metabolic syndrome is a group of risk factors (obesity, hypertension, high fasting blood sugar, and high levels of triglycerides) that increase the risk of type 2 diabetes and cardiovascular diseases.

Brain disorders and disease represent an immense societal burden and the leading cost to the Canadian health care system.

Ependymal cells are a largely understudied barrier cell type in the brain that provide a wall between brain tissue and brain fluid (cerebral spinal fluid, CSF), playing an important role in regulating fluid balance.

In the past decade, rapid development of software has allowed detection of a wide variety of genetic risk factors in brain disorders.

Autism spectrum disorder (ASD) affects approximately 1 in 70 children and is associated to a considerable burden for affected individuals, their families, and health care at large.

Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most common and devastating neurological diseases, with over 750,000 AD patients and over 100,000 PD patients in Canada.

Canada recently became the first G7 nation to legalize Cannabis for medicinal and recreational use.

The human experience is marked by constant learning.